//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
1d
Seeking a post-doc for the LaJoie lab at the Human Technopole, Milan, Italy! We are looking for candidates from the fields of biochemistry, cell biology, and proteomics, who are interested in studying protein interactions of the nucleus 🤓 lnkd.in/dTG2CgXF
Dollie LaJoie
2d
Watching phantastic youtube video by heidelberg.ai of lecture of Simon Kohl @ AlphaFold to prepare for a lecture (www.youtube.com/watch?v=tTN0...). It was recorded in 2022, so his made me a bit sentimental for good old sciencetwitter.
1d
If there ever was evidence for people being reborn as animals, this is totally what I would to to protect myself if I was reborn as a caterpillar.
Standing ovations for the new daraxonasib at ASCO meeting. Amazing breakthrough, hooray for science!
6d
10d
Data as LLM
15d
Sunny Wednesday morning, another great day to do science!
…“only Keytruda”… progress is just stunning
very cool study using ExM to find AnkG organization in AIS: www.biorxiv.org/content/10.6...
Ewerslab
And here we go: there is the 50 mm HeLa cell:
1d
10d
10d
Ewerslab
10d
Ewerslab
Ewerslab
Ewerslab
Ewerslab
Ewerslab
Ewerslab
Ewerslab
ALT: a knight with a helmet and a sword says " this is the way "
media.tenor.com
a knight with a helmet and a sword says " this is the way "
www.biorxiv.org
A bagworm caterpillar carrying a protective case it built from twigs and silk. [📹Brunno Tavarez] Original post
7d
Video
Massimo (mirror)
In the study, “92% of patients who received the combination therapy were alive at the five-year mark, compared with 71% of those who only used Keytruda… "I think this is a landmark advance in how we treat these very advanced, high-risk melanomas”
10d
Kathleen Bachynski
Major news from #ASCO26: A multi-selective RAS(ON) inhibitor nearly doubles survival time in people with metastatic pancreatic cancer. “This is absolutely practice-changing” says Dr. Shruti Patel in this Science in Seconds. #pancan Read the abstract: https://bit.ly/4dChEWM
10d
Ok this is a truly great tweet
15d
American Society of Clinical Oncology
No Sunk Costs
Thousandfold Expansion Microscopy https://www.biorxiv.org/content/10.64898/2026.05.31.729018v1
10d
bioRxivpreprint
Video